CN1337246A - Chinese medicine for treating cerebral thrombus sequelae - Google Patents
Chinese medicine for treating cerebral thrombus sequelae Download PDFInfo
- Publication number
- CN1337246A CN1337246A CN 00121234 CN00121234A CN1337246A CN 1337246 A CN1337246 A CN 1337246A CN 00121234 CN00121234 CN 00121234 CN 00121234 A CN00121234 A CN 00121234A CN 1337246 A CN1337246 A CN 1337246A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- herba
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine for curing cerebral thrombosis and its sequelae, numbness of hands and feet, apoplexy and traumatic injury with reliable therapeutic effect is made up by using 55 Chinese medicinal materials of benzoin, ginseng, agkistrodon, Chinese angelica root, ligusticum root, Sichuan coptis root and others. It is reasonable in prescription, can quickly obtain effect, and has no toxic side effect.
Description
The invention belongs to the formulated preparation of a kind of natural Chinese medicines plant.Be mainly used in the treatment cerebral infarction sequela as: facial hemiparalysis, carpopedal spasm, slurred speech, bones and muscles pain, hemiplegia, walk with difficulty.The all right simultaneously formation and the cerebral arteriosclerosis of preventing thrombosis in advance.
Still do not have effective way at present and effect a radical cure these diseases, ideal method is to carry out the treatment of α cutter, and this way is that costliness can not be effected a radical cure sequela again, also is a kind of damaging treatment simultaneously.Therefore, feel not quite the thing behind some human therapy, even symptom such as headache appears, and not only can not play ideal effect, damaged healthy on the contrary, in recent years many manufacturer production the Chinese medicine and western medicine of relevant treatment cerebral thrombosis, but curative effect is not good enough, and cure rate is low, and the Chinese medicine that has has also added valuable medicines such as Moschus, cost is higher, also is not suitable for extensive patients and buys.
The objective of the invention is to effect a radical cure cerebral infarction sequela, can also prevent thrombosis and arteriosclerotic medicine simultaneously with a kind of of pure Chinese medicine preparation.
Product of the present invention; it is characterized in that by Benzoinum; Radix Ginseng; Agkistrodon; Radix Angelicae Sinensis; Rhizoma Chuanxiong; Rhizoma Coptidis; Rhizoma Et Radix Notopterygii; Radix Saposhnikoviae; Radix Scrophulariae; Herba Pogostemonis; the Radix Angelicae Dahuricae; Poria; Herba Ephedrae; Rhizoma Gastrodiae; Rhizoma Smilacis ; Rhizoma Wenyujin Concisum; Radix Glycyrrhizae; Cortex Cinnamomi; roud cardamon seed; the Radix Polygoni Multiflori; succinum; the Radix Astragali; Radix Et Rhizoma Rhei; Semen Alpiniae Katsumadai; Radix Rehmanniae Preparata; Squama Manis; Scorpio; Radix Clematidis; Radix Puerariae; Herba Taxilli; Herba Asari; Radix Paeoniae Rubra; the Radix Linderae; Pericarpium Citri Reticulatae Viride; the what art; Bombyx Batryticatus; Olibanum; Myrrha; cinnabar; Rhizoma Drynariae; Rhizoma Cyperi; Concretio Silicea Bambusae; Radix Aconiti Lateralis Preparata; give birth to Carapax et Plastrum Testudinis; Lignum Aquilariae Resinatum; Flos Caryophylli; Arisaema Cum Bile; Flos Carthami; Cortex Magnoliae Officinalis; Pheretima; Colophonium; the Radix Aucklandiae; Borneolum Syntheticum; Calculus Bovis; 55 flavor Chinese medicines such as Sanguis Draxonis are formed, and the shared share of must measuring of each medicine is respectively: Benzoinum 240g; Radix Ginseng 140g; one of Agkistrodon; Radix Angelicae Sinensis 140g; Rhizoma Chuanxiong 140g; Rhizoma Coptidis 140g; Rhizoma Et Radix Notopterygii 140g; Radix Saposhnikoviae 140g; Radix Scrophulariae 140g; Herba Pogostemonis 140g; Radix Angelicae Dahuricae 140g; Poria 140g; Herba Ephedrae 140g; Rhizoma Gastrodiae 140g; Rhizoma Smilacis 140g; Rhizoma Wenyujin Concisum 140g; Radix Glycyrrhizae 140g; Cortex Cinnamomi 140g; roud cardamon seed 140g; Radix Polygoni Multiflori 140g; succinum 140g; Radix Astragali 140g; Radix Et Rhizoma Rhei 140g; Semen Alpiniae Katsumadai 140g; Radix Rehmanniae Preparata 140g; Squama Manis 140g; Scorpio 150g; Radix Clematidis 150g; Radix Puerariae 150g; Herba Taxilli 150g; Herba Asari 120g; Radix Paeoniae Rubra 120g; Radix Linderae 120g; Pericarpium Citri Reticulatae Viride 120g; what art 120g; Bombyx Batryticatus 120g; Olibanum 120g; Myrrha 120g; cinnabar 120g; Rhizoma Drynariae 120g; Rhizoma Cyperi 120g; Concretio Silicea Bambusae 120g; Radix Aconiti Lateralis Preparata 120g; give birth to Carapax et Plastrum Testudinis 120 murky fragrant 120g; Flos Caryophylli 120g; Arisaema Cum Bile 120g; Flos Carthami 50g; Cortex Magnoliae Officinalis 30g; Pheretima 30g; Colophonium 30g; Radix Aucklandiae 20g; Borneolum Syntheticum 12.5g; Calculus Bovis 12.5g; Sanguis Draxonis 12.5g.
The processing worker flow process of product of the present invention is followed successively by: select medicine, and------oven dry---is pulverized---sterilization---encapsulated---sterilization---packing---warehouse-in to wash.
Medicine grinding particle size 180 orders.
Product of the present invention has following advantage compared with the prior art:
Products characteristics of the present invention is: 1, do not use valuable medicines such as Moschus, reduce cost greatly; 2, this product can take effect within the short time; 3, from prescription observation of curative effect cure rate height; 4, product of the present invention is oral pure Chinese medicine medicine, can be after oral fast with the old thromboembolism, and make sequela obtain curing.
The present invention fills a prescription rationally, and medicine time is short, treating both the principal and secondary aspects of a disease, and do not recur, used Chinese medicine is wild natural green plant, and is pollution-free, has no side effect.
According to the foregoing invention scheme, now for the embodiment of two different proportionings:
1; Benzoinum 65g; Radix Ginseng 65g; one of Agkistrodon; Radix Angelicae Sinensis 65g; Rhizoma Chuanxiong 65g; Rhizoma Coptidis 65g; Rhizoma Et Radix Notopterygii 65g; Radix Saposhnikoviae 65g; Radix Scrophulariae 65g; Herba Pogostemonis 65g; Radix Angelicae Dahuricae 65g; Poria 65g; Herba Ephedrae 65g; Rhizoma Gastrodiae 65g; Rhizoma Smilacis 65g; Rhizoma Wenyujin Concisum 65g; Radix Glycyrrhizae 65g; Cortex Cinnamomi 65g; roud cardamon seed 65g; Radix Polygoni Multiflori 65g; succinum 65g; Radix Astragali 65g; Radix Et Rhizoma Rhei 65g; Semen Alpiniae Katsumadai 65g; Radix Rehmanniae Preparata 65g; Squama Manis 65g; Scorpio 65g; Radix Clematidis 65g; Radix Puerariae 65g; Herba Taxilli 65g; Herba Asari 65g; Radix Paeoniae Rubra 65g; Radix Linderae 65g; Pericarpium Citri Reticulatae Viride 65g; what art 65g; Bombyx Batryticatus 65g; Olibanum 65g; Myrrha 65g; cinnabar 65g; Rhizoma Drynariae 65g; Rhizoma Cyperi 65g; Concretio Silicea Bambusae 65g; Radix Aconiti Lateralis Preparata 65g; give birth to Carapax et Plastrum Testudinis 65g; Lignum Aquilariae Resinatum 65g; Flos Caryophylli 65g; Arisaema Cum Bile 65g; Flos Carthami 65g; Cortex Magnoliae Officinalis 65g; Pheretima 65g; Colophonium 65g; Radix Aucklandiae 65g; Borneolum Syntheticum 1.6g; Calculus Bovis 12.5g; Sanguis Draxonis 12.5g.
2; Benzoinum 45g; Radix Ginseng 45g; one of Agkistrodon; Radix Angelicae Sinensis 45g; Rhizoma Chuanxiong 45g; Rhizoma Coptidis 45g; Rhizoma Et Radix Notopterygii 45g; Radix Saposhnikoviae 45g; Radix Scrophulariae 45g; Herba Pogostemonis 45g; Radix Angelicae Dahuricae 45g; Poria 45g; Herba Ephedrae 45g; Rhizoma Gastrodiae 45g; Rhizoma Smilacis 45g; Rhizoma Wenyujin Concisum 45g; Radix Glycyrrhizae 45g; Cortex Cinnamomi 45g; roud cardamon seed 45g; Radix Polygoni Multiflori 45g; succinum 45g; Radix Astragali 45g; Radix Et Rhizoma Rhei 45g; Semen Alpiniae Katsumadai 45g; Radix Rehmanniae Preparata 45g; Squama Manis 45g; Scorpio 45g; Radix Clematidis 45g; Radix Puerariae 45g; Herba Taxilli 45g; Herba Asari 45g; Radix Paeoniae Rubra 45g; Radix Linderae 45g; Pericarpium Citri Reticulatae Viride 45g; what art 45g; Bombyx Batryticatus 45g; Olibanum 45g; Myrrha 45g; cinnabar 45g; Rhizoma Drynariae 45g; Rhizoma Cyperi 45g; Concretio Silicea Bambusae 45g; Radix Aconiti Lateralis Preparata 45g; give birth to Carapax et Plastrum Testudinis 45g; Lignum Aquilariae Resinatum 45g; Flos Caryophylli 45g; Arisaema Cum Bile 45g; Flos Carthami 45g; Cortex Magnoliae Officinalis 45g; Pheretima 45g; Colophonium 45g; Radix Aucklandiae 45g; Borneolum Syntheticum 1.2g; Calculus Bovis 6g; Sanguis Draxonis 4g.
The capsule of last two routine reagent, the person took 4 days through suffering from the cerebral infarction sequela, and speech, walking improve good, take and can make the old thromboembolism in 20 days, prove that through practicality non-relapse after healing reflects well with the person, and sequela is clearly better.
The patient that selection suffers from cerebral infarction sequela takes the product that makes according to embodiment one, the thrombosis sheet that control drug is produced for certain factory, two medicines oral one month respectively, every day three times, each three, observe 1 year by its curative effect of visual determination, the curative effect discrimination standard is:
1, recovery from illness: take medicine and do not see the symptom that sequela occurs in back 1 year.
2, produce effects: taking medicine, sequela obviously alleviates in back 1 year, but walking is not also not freely.
3, effective: the back disease of taking medicine alleviates, recurrence again after the drug withdrawal.
4, invalid: the back disease of taking medicine does not have change.
Curative effect sees Table one, and this table is this invention medicine contrast medicine thrombosis sheet (certain factory produces).Observed 1 annual earnings effect (selecting the cerebral infarction sequela patient) in all oral 1 month:
| Kind | The observation number | The recovery from illness number | The produce effects number | Effective number | Invalid number | Total effective rate |
| Medicine of the present invention | ????85 | ????81 | ????2 | ????1 | ????1 | ??98.8％ |
| The thrombosis sheet | ????85 | ????30 | ????32 | ????12 | ????11 | ??87.1％ |
As can be seen from Table I, the present invention can play prevention and therapeutical effect to the formation of thrombosis, and is evident in efficacy to sequela.Through observation on Clinical Application, demonstrated following superiority:
1, the present invention is 98.8% to thrombosis and thrombus sequela effective percentage, have easy to carry, short treating period, instant effect, the characteristics that radical rate is high.
2, used medicine is wild medicine commonly used in the prescription, all can according to " pharmacopeia " record oral administration and externally.In clinical observation, there is not toxicity.
3, medicine of the present invention can also be treated numb hand and foot, middle apoplexy due to phlegm wind.In addition, can control traumatic injury, mix well with wine and spread on outside the trouble.
Claims (2)
1, a kind of Chinese medicine for the treatment of cerebral infarction sequela is characterized in that being made up of following materials of weight proportions:
Benzoinum 65g; Radix Ginseng 65g; one of Agkistrodon; Radix Angelicae Sinensis 65g; Rhizoma Chuanxiong 65g; Rhizoma Coptidis 65g; Rhizoma Et Radix Notopterygii 65g; Radix Saposhnikoviae 65g; Radix Scrophulariae 65g; Herba Pogostemonis 65g; Radix Angelicae Dahuricae 65g; Poria 65g; Herba Ephedrae 65g; Rhizoma Gastrodiae 65g; Rhizoma Smilacis 65g; Rhizoma Wenyujin Concisum 65g; Radix Glycyrrhizae 65g; Cortex Cinnamomi 65g; roud cardamon seed 65g; Radix Polygoni Multiflori 65g; succinum 65g; Radix Astragali 65g; Radix Et Rhizoma Rhei 65g; Semen Alpiniae Katsumadai 65g; Radix Rehmanniae Preparata 65g; Squama Manis 65g; Scorpio 65g; Radix Clematidis 65g; Radix Puerariae 65g; Herba Taxilli 65g; Herba Asari 65g; Radix Paeoniae Rubra 65g; Radix Linderae 65g; Pericarpium Citri Reticulatae Viride 65g; what art 65g; Bombyx Batryticatus 65g; Olibanum 65g; Myrrha 65g; cinnabar 65g; Rhizoma Drynariae 65g; Rhizoma Cyperi 65g; Concretio Silicea Bambusae 65g; Radix Aconiti Lateralis Preparata 65g; give birth to Carapax et Plastrum Testudinis 65g; Lignum Aquilariae Resinatum 65g; Flos Caryophylli 65g; Arisaema Cum Bile 65g; Flos Carthami 65g; Cortex Magnoliae Officinalis 65g; Pheretima 65g; Colophonium 65g; Radix Aucklandiae 65g; Borneolum Syntheticum 1.6g; Calculus Bovis 12.5g; Sanguis Draxonis 12.5g.
2, the method for the Chinese medicine of the described treatment cerebral infarction sequela of preparation claim 1 is characterized in that may further comprise the steps:
Select medicine → wash → oven dry → pulverizing → metering → packing
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00121234 CN1337246A (en) | 2000-08-09 | 2000-08-09 | Chinese medicine for treating cerebral thrombus sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00121234 CN1337246A (en) | 2000-08-09 | 2000-08-09 | Chinese medicine for treating cerebral thrombus sequelae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1337246A true CN1337246A (en) | 2002-02-27 |
Family
ID=4588666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00121234 Pending CN1337246A (en) | 2000-08-09 | 2000-08-09 | Chinese medicine for treating cerebral thrombus sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1337246A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100353995C (en) * | 2003-07-01 | 2007-12-12 | 王焕寅 | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin |
| CN100443094C (en) * | 2004-09-06 | 2008-12-17 | 青岛国风药业股份有限公司 | Oral Chinese medicinal composition for treating apoplexia |
| CN103610870A (en) * | 2013-12-12 | 2014-03-05 | 侯书圣 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
| CN103784893A (en) * | 2014-03-07 | 2014-05-14 | 王有彬 | Medicine for treating sequela of cerebra apoplexy |
| CN104001086A (en) * | 2014-06-04 | 2014-08-27 | 湖州康企药业有限公司 | Medicine for treating sequela of apoplexy |
| CN101700364B (en) * | 2009-11-12 | 2014-12-10 | 张国营 | Thrombolytic and lipid-lowering pill |
| CN105267561A (en) * | 2015-11-06 | 2016-01-27 | 王小芬 | Cardiovascular and cerebrovascular disease treatment medicine for oral administration and preparation method of cardiovascular and cerebrovascular disease treatment medicine for oral administration |
| CN110090284A (en) * | 2019-05-13 | 2019-08-06 | 北京南亚医学研究院 | A kind of Chinese medicine microecological preparation and its preparation method and application |
-
2000
- 2000-08-09 CN CN 00121234 patent/CN1337246A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100353995C (en) * | 2003-07-01 | 2007-12-12 | 王焕寅 | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin |
| CN100443094C (en) * | 2004-09-06 | 2008-12-17 | 青岛国风药业股份有限公司 | Oral Chinese medicinal composition for treating apoplexia |
| CN101700364B (en) * | 2009-11-12 | 2014-12-10 | 张国营 | Thrombolytic and lipid-lowering pill |
| CN103610870A (en) * | 2013-12-12 | 2014-03-05 | 侯书圣 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
| CN103610870B (en) * | 2013-12-12 | 2016-04-13 | 侯书圣 | A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease |
| CN103784893A (en) * | 2014-03-07 | 2014-05-14 | 王有彬 | Medicine for treating sequela of cerebra apoplexy |
| CN103784893B (en) * | 2014-03-07 | 2016-04-27 | 王有彬 | A kind of medicine for the treatment of cerebral apoplexy sequela |
| CN104001086A (en) * | 2014-06-04 | 2014-08-27 | 湖州康企药业有限公司 | Medicine for treating sequela of apoplexy |
| CN105267561A (en) * | 2015-11-06 | 2016-01-27 | 王小芬 | Cardiovascular and cerebrovascular disease treatment medicine for oral administration and preparation method of cardiovascular and cerebrovascular disease treatment medicine for oral administration |
| CN110090284A (en) * | 2019-05-13 | 2019-08-06 | 北京南亚医学研究院 | A kind of Chinese medicine microecological preparation and its preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102228485B (en) | Composition for burn rehabilitation and preparation method thereof | |
| CN100478020C (en) | Stomatocase treating medicine | |
| CN1337246A (en) | Chinese medicine for treating cerebral thrombus sequelae | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN1071123C (en) | Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites | |
| CN101214365A (en) | Chinese medicine composing prescription for treating mastoproliferation | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
| CN1931268B (en) | Acne treating medicine | |
| CN103157006B (en) | Oral traditional Chinese medicine formula for treating osteoarthritis | |
| CN1060076C (en) | Gucixiao pill for removing spur | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN100340272C (en) | Headache-treating medicine | |
| CN1322558A (en) | Liver cancer resisting medicine | |
| CN103705898A (en) | Traditional Chinese medicine composition for treating acnes | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN103316291A (en) | Anti acne of traditional Chinese medicine | |
| CN102743524B (en) | Traditional Chinese medicine for treating rheumatism | |
| CN101584839A (en) | Chinese medicament for treating acute and chronic cholecystitis | |
| CN1067891C (en) | Pure Chinese drug for curing cerebral thrambus | |
| CN106389721A (en) | Traditional Chinese medicine lotion for removing dandruff and preparation method of traditional Chinese medicine lotion | |
| CN101129694A (en) | Traditional Chinese medicine for treating muscular contraction headache | |
| CN105663679A (en) | Traditional Chinese medicine composition for treating ichthyosis | |
| CN1064844C (en) | Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhou Kenxi Document name: Notice of publication of application for patent for invention |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhou Kenxi Document name: Notification before expiration of term |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhou Kenxi Document name: Deemed as a notice of withdrawal |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |